{"transactions":[{"id":3170445,"issuer":{"id":4970,"kind":"organization","name":"LEXICON PHARMACEUTICALS, INC."},"owners":[{"id":149674,"kind":"person","name":"Lapuerta Pablo","position":1,"cik":"0001516368","reported_name":"Lapuerta Pablo","relationship":{"officer":true,"officer_title":"EVP and CMO"}}],"security":"Common Stock","published_at":"2020-04-24T21:02:57.000Z","date":"2020-04-22","kind":"tax_withholding","acquired":false,"shares":6813,"price":1.96,"value":13353.48,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"Withholding of a portion of issued shares by the Company in satisfaction of shareholder's tax withholding obligations with respect thereto."}],"balance_after":85719,"source":{"system":"sec-edgar","filing":"0001127602-20-014487","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1062822/000112760220014487/form4.xml","form_type":"4"}},{"id":3170444,"issuer":{"id":4970,"kind":"organization","name":"LEXICON PHARMACEUTICALS, INC."},"owners":[{"id":149674,"kind":"person","name":"Lapuerta Pablo","position":1,"cik":"0001516368","reported_name":"Lapuerta Pablo","relationship":{"officer":true,"officer_title":"EVP and CMO"}}],"security":"Common Stock","published_at":"2020-04-24T21:02:57.000Z","date":"2020-04-22","kind":"grant","acquired":true,"shares":19893,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Issued upon vesting of performance-based restricted stock units granted on December 5, 2019, the vesting of which was determined by the compensation committee in its sole discretion based on pre-specified corporate goals."}],"balance_after":92532,"source":{"system":"sec-edgar","filing":"0001127602-20-014487","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1062822/000112760220014487/form4.xml","form_type":"4"}},{"id":3233982,"issuer":{"id":4970,"kind":"organization","name":"LEXICON PHARMACEUTICALS, INC."},"owners":[{"id":149674,"kind":"person","name":"Lapuerta Pablo","position":1,"cik":"0001516368","reported_name":"Lapuerta Pablo","relationship":{"officer":true,"officer_title":"EVP and CMO"}}],"security":"Restricted Stock Units","published_at":"2020-03-03T21:15:17.000Z","date":"2020-02-28","kind":"exercise","acquired":false,"shares":23463,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of common stock."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"Restricted stock units vest with respect to one third of the shares subject to the restricted stock units on February 28, 2020 and vest an additional one third on February 28 of each of the two succeeding years thereafter."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F6","text":"Restricted stock units vest with respect to one third of the shares subject to the restricted stock units on February 28, 2020 and vest an additional one third on February 28 of each of the two succeeding years thereafter."}],"balance_after":46927,"derivative":{"underlying":"Common Stock","underlying_shares":23463},"source":{"system":"sec-edgar","filing":"0001127602-20-008962","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1062822/000112760220008962/form4.xml","form_type":"4"}},{"id":3233981,"issuer":{"id":4970,"kind":"organization","name":"LEXICON PHARMACEUTICALS, INC."},"owners":[{"id":149674,"kind":"person","name":"Lapuerta Pablo","position":1,"cik":"0001516368","reported_name":"Lapuerta Pablo","relationship":{"officer":true,"officer_title":"EVP and CMO"}}],"security":"Restricted Stock Units","published_at":"2020-03-03T21:15:17.000Z","date":"2020-02-28","kind":"exercise","acquired":false,"shares":8570,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of common stock."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"Restricted stock units vest with respect to one third of the shares subject to the restricted stock units on February 28, 2019 and vest an additional one third on February 28 of each of the two succeeding years thereafter."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"Restricted stock units vest with respect to one third of the shares subject to the restricted stock units on February 28, 2019 and vest an additional one third on February 28 of each of the two succeeding years thereafter."}],"balance_after":8570,"derivative":{"underlying":"Common Stock","underlying_shares":8570},"source":{"system":"sec-edgar","filing":"0001127602-20-008962","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1062822/000112760220008962/form4.xml","form_type":"4"}},{"id":3233980,"issuer":{"id":4970,"kind":"organization","name":"LEXICON PHARMACEUTICALS, INC."},"owners":[{"id":149674,"kind":"person","name":"Lapuerta Pablo","position":1,"cik":"0001516368","reported_name":"Lapuerta Pablo","relationship":{"officer":true,"officer_title":"EVP and CMO"}}],"security":"Restricted Stock Units","published_at":"2020-03-03T21:15:17.000Z","date":"2020-02-28","kind":"exercise","acquired":false,"shares":2585,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of common stock."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Restricted stock units vest with respect to 25% of the shares subject to the restricted stock units on February 28, 2018 and vest an additional 25% on February 28 of each of the three succeeding years thereafter."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"Restricted stock units vest with respect to 25% of the shares subject to the restricted stock units on February 28, 2018 and vest an additional 25% on February 28 of each of the three succeeding years thereafter."}],"balance_after":2585,"derivative":{"underlying":"Common Stock","underlying_shares":2585},"source":{"system":"sec-edgar","filing":"0001127602-20-008962","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1062822/000112760220008962/form4.xml","form_type":"4"}},{"id":3233979,"issuer":{"id":4970,"kind":"organization","name":"LEXICON PHARMACEUTICALS, INC."},"owners":[{"id":149674,"kind":"person","name":"Lapuerta Pablo","position":1,"cik":"0001516368","reported_name":"Lapuerta Pablo","relationship":{"officer":true,"officer_title":"EVP and CMO"}}],"security":"Restricted Stock Units","published_at":"2020-03-03T21:15:17.000Z","date":"2020-02-28","kind":"exercise","acquired":false,"shares":4228,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of common stock."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Restricted stock units vest with respect to 25% of the shares subject to the restricted stock units on February 28, 2017 and vest an additional 25% on February 28 of each of the three succeeding years thereafter."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Restricted stock units vest with respect to 25% of the shares subject to the restricted stock units on February 28, 2017 and vest an additional 25% on February 28 of each of the three succeeding years thereafter."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":4228},"source":{"system":"sec-edgar","filing":"0001127602-20-008962","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1062822/000112760220008962/form4.xml","form_type":"4"}},{"id":3233978,"issuer":{"id":4970,"kind":"organization","name":"LEXICON PHARMACEUTICALS, INC."},"owners":[{"id":149674,"kind":"person","name":"Lapuerta Pablo","position":1,"cik":"0001516368","reported_name":"Lapuerta Pablo","relationship":{"officer":true,"officer_title":"EVP and CMO"}}],"security":"Common Stock","published_at":"2020-03-03T21:15:17.000Z","date":"2020-02-28","kind":"tax_withholding","acquired":false,"shares":13305,"price":2.77,"value":36854.85,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"Withholding of a portion of issued shares by the Company in satisfaction of shareholder's tax withholding obligations with respect thereto."}],"balance_after":72639,"source":{"system":"sec-edgar","filing":"0001127602-20-008962","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1062822/000112760220008962/form4.xml","form_type":"4"}},{"id":3233977,"issuer":{"id":4970,"kind":"organization","name":"LEXICON PHARMACEUTICALS, INC."},"owners":[{"id":149674,"kind":"person","name":"Lapuerta Pablo","position":1,"cik":"0001516368","reported_name":"Lapuerta Pablo","relationship":{"officer":true,"officer_title":"EVP and CMO"}}],"security":"Common Stock","published_at":"2020-03-03T21:15:17.000Z","date":"2020-02-28","kind":"exercise","acquired":true,"shares":23463,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of common stock."}],"balance_after":85944,"source":{"system":"sec-edgar","filing":"0001127602-20-008962","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1062822/000112760220008962/form4.xml","form_type":"4"}},{"id":3233976,"issuer":{"id":4970,"kind":"organization","name":"LEXICON PHARMACEUTICALS, INC."},"owners":[{"id":149674,"kind":"person","name":"Lapuerta Pablo","position":1,"cik":"0001516368","reported_name":"Lapuerta Pablo","relationship":{"officer":true,"officer_title":"EVP and CMO"}}],"security":"Common Stock","published_at":"2020-03-03T21:15:17.000Z","date":"2020-02-28","kind":"exercise","acquired":true,"shares":8570,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of common stock."}],"balance_after":62481,"source":{"system":"sec-edgar","filing":"0001127602-20-008962","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1062822/000112760220008962/form4.xml","form_type":"4"}},{"id":3233975,"issuer":{"id":4970,"kind":"organization","name":"LEXICON PHARMACEUTICALS, INC."},"owners":[{"id":149674,"kind":"person","name":"Lapuerta Pablo","position":1,"cik":"0001516368","reported_name":"Lapuerta Pablo","relationship":{"officer":true,"officer_title":"EVP and CMO"}}],"security":"Common Stock","published_at":"2020-03-03T21:15:17.000Z","date":"2020-02-28","kind":"exercise","acquired":true,"shares":2585,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of common stock."}],"balance_after":53911,"source":{"system":"sec-edgar","filing":"0001127602-20-008962","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1062822/000112760220008962/form4.xml","form_type":"4"}},{"id":3233974,"issuer":{"id":4970,"kind":"organization","name":"LEXICON PHARMACEUTICALS, INC."},"owners":[{"id":149674,"kind":"person","name":"Lapuerta Pablo","position":1,"cik":"0001516368","reported_name":"Lapuerta Pablo","relationship":{"officer":true,"officer_title":"EVP and CMO"}}],"security":"Common Stock","published_at":"2020-03-03T21:15:17.000Z","date":"2020-02-28","kind":"exercise","acquired":true,"shares":4228,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of common stock."}],"balance_after":51326,"source":{"system":"sec-edgar","filing":"0001127602-20-008962","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1062822/000112760220008962/form4.xml","form_type":"4"}},{"id":3282937,"issuer":{"id":4970,"kind":"organization","name":"LEXICON PHARMACEUTICALS, INC."},"owners":[{"id":149674,"kind":"person","name":"Lapuerta Pablo","position":1,"cik":"0001516368","reported_name":"Lapuerta Pablo","relationship":{"officer":true,"officer_title":"EVP and CMO"}}],"security":"Stock Option (Right to Buy)","published_at":"2020-02-10T21:07:48.000Z","date":"2020-02-06","kind":"grant","acquired":true,"shares":247220,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Option vests with respect to 25% of the shares subject to the option on the first anniversary of grant, and vests 1/48th per month for each month of service thereafter."}],"balance_after":247220,"derivative":{"exercise_price":3.31,"expiration_date":"2030-02-06","underlying":"Common Stock","underlying_shares":247220},"source":{"system":"sec-edgar","filing":"0001127602-20-004591","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1062822/000112760220004591/form4.xml","form_type":"4"}},{"id":3282936,"issuer":{"id":4970,"kind":"organization","name":"LEXICON PHARMACEUTICALS, INC."},"owners":[{"id":149674,"kind":"person","name":"Lapuerta Pablo","position":1,"cik":"0001516368","reported_name":"Lapuerta Pablo","relationship":{"officer":true,"officer_title":"EVP and CMO"}}],"security":"Restricted Stock Units","published_at":"2020-02-10T21:07:48.000Z","date":"2020-02-06","kind":"grant","acquired":true,"shares":82410,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Restricted stock units vest with respect to 1/3 of the shares subject to the restricted stock units on February 28 of each of the three years following the year of grant."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Restricted stock units vest with respect to 1/3 of the shares subject to the restricted stock units on February 28 of each of the three years following the year of grant."}],"balance_after":82410,"derivative":{"underlying":"Common Stock","underlying_shares":82410},"source":{"system":"sec-edgar","filing":"0001127602-20-004591","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1062822/000112760220004591/form4.xml","form_type":"4"}},{"id":3624058,"issuer":{"id":4970,"kind":"organization","name":"LEXICON PHARMACEUTICALS, INC."},"owners":[{"id":149674,"kind":"person","name":"Lapuerta Pablo","position":1,"cik":"0001516368","reported_name":"Lapuerta Pablo","relationship":{"officer":true,"officer_title":"EVP and CMO"}}],"security":"Restricted Stock Units","published_at":"2019-03-01T22:16:33.000Z","date":"2019-02-28","kind":"exercise","acquired":false,"shares":8570,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of common stock."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"Restricted stock units vest with respect to one third of the shares subject to the restricted stock units on February 28, 2019 and vest an additional one third on February 28 of each of the two succeeding years thereafter."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F6","text":"Restricted stock units vest with respect to one third of the shares subject to the restricted stock units on February 28, 2019 and vest an additional one third on February 28 of each of the two succeeding years thereafter."}],"balance_after":17140,"derivative":{"underlying":"Common Stock","underlying_shares":8570},"source":{"system":"sec-edgar","filing":"0001127602-19-009261","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1062822/000112760219009261/form4.xml","form_type":"4"}},{"id":3624057,"issuer":{"id":4970,"kind":"organization","name":"LEXICON PHARMACEUTICALS, INC."},"owners":[{"id":149674,"kind":"person","name":"Lapuerta Pablo","position":1,"cik":"0001516368","reported_name":"Lapuerta Pablo","relationship":{"officer":true,"officer_title":"EVP and CMO"}}],"security":"Restricted Stock Units","published_at":"2019-03-01T22:16:33.000Z","date":"2019-02-28","kind":"exercise","acquired":false,"shares":2585,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of common stock."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"Restricted stock units vest with respect to 25% of the shares subject to the restricted stock units on February 28, 2018 and vest an additional 25% on February 28 of each of the three succeeding years thereafter."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"Restricted stock units vest with respect to 25% of the shares subject to the restricted stock units on February 28, 2018 and vest an additional 25% on February 28 of each of the three succeeding years thereafter."}],"balance_after":5170,"derivative":{"underlying":"Common Stock","underlying_shares":2585},"source":{"system":"sec-edgar","filing":"0001127602-19-009261","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1062822/000112760219009261/form4.xml","form_type":"4"}},{"id":3624056,"issuer":{"id":4970,"kind":"organization","name":"LEXICON PHARMACEUTICALS, INC."},"owners":[{"id":149674,"kind":"person","name":"Lapuerta Pablo","position":1,"cik":"0001516368","reported_name":"Lapuerta Pablo","relationship":{"officer":true,"officer_title":"EVP and CMO"}}],"security":"Restricted Stock Units","published_at":"2019-03-01T22:16:33.000Z","date":"2019-02-28","kind":"exercise","acquired":false,"shares":4227,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of common stock."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Restricted stock units vest with respect to 25% of the shares subject to the restricted stock units on February 28, 2017 and vest an additional 25% on February 28 of each of the three succeeding years thereafter."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"Restricted stock units vest with respect to 25% of the shares subject to the restricted stock units on February 28, 2017 and vest an additional 25% on February 28 of each of the three succeeding years thereafter."}],"balance_after":4228,"derivative":{"underlying":"Common Stock","underlying_shares":4227},"source":{"system":"sec-edgar","filing":"0001127602-19-009261","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1062822/000112760219009261/form4.xml","form_type":"4"}},{"id":3624055,"issuer":{"id":4970,"kind":"organization","name":"LEXICON PHARMACEUTICALS, INC."},"owners":[{"id":149674,"kind":"person","name":"Lapuerta Pablo","position":1,"cik":"0001516368","reported_name":"Lapuerta Pablo","relationship":{"officer":true,"officer_title":"EVP and CMO"}}],"security":"Restricted Stock Units","published_at":"2019-03-01T22:16:33.000Z","date":"2019-02-28","kind":"exercise","acquired":false,"shares":4550,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of common stock."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Restricted stock units vest with respect to 25% of the shares subject to the restricted stock units on February 28, 2016 and vest an additional 25% on February 28 of each of the three succeeding years thereafter."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Restricted stock units vest with respect to 25% of the shares subject to the restricted stock units on February 28, 2016 and vest an additional 25% on February 28 of each of the three succeeding years thereafter."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":4550},"source":{"system":"sec-edgar","filing":"0001127602-19-009261","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1062822/000112760219009261/form4.xml","form_type":"4"}},{"id":3624054,"issuer":{"id":4970,"kind":"organization","name":"LEXICON PHARMACEUTICALS, INC."},"owners":[{"id":149674,"kind":"person","name":"Lapuerta Pablo","position":1,"cik":"0001516368","reported_name":"Lapuerta Pablo","relationship":{"officer":true,"officer_title":"EVP and CMO"}}],"security":"Common Stock","published_at":"2019-03-01T22:16:33.000Z","date":"2019-02-28","kind":"tax_withholding","acquired":false,"shares":6809,"price":5.51,"value":37517.59,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"Withholding of a portion of issued shares by the Company in satisfaction of shareholder's tax withholding obligations with respect thereto."}],"balance_after":47098,"source":{"system":"sec-edgar","filing":"0001127602-19-009261","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1062822/000112760219009261/form4.xml","form_type":"4"}},{"id":3624053,"issuer":{"id":4970,"kind":"organization","name":"LEXICON PHARMACEUTICALS, INC."},"owners":[{"id":149674,"kind":"person","name":"Lapuerta Pablo","position":1,"cik":"0001516368","reported_name":"Lapuerta Pablo","relationship":{"officer":true,"officer_title":"EVP and CMO"}}],"security":"Common Stock","published_at":"2019-03-01T22:16:33.000Z","date":"2019-02-28","kind":"exercise","acquired":true,"shares":8570,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of common stock."}],"balance_after":53907,"source":{"system":"sec-edgar","filing":"0001127602-19-009261","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1062822/000112760219009261/form4.xml","form_type":"4"}},{"id":3624052,"issuer":{"id":4970,"kind":"organization","name":"LEXICON PHARMACEUTICALS, INC."},"owners":[{"id":149674,"kind":"person","name":"Lapuerta Pablo","position":1,"cik":"0001516368","reported_name":"Lapuerta Pablo","relationship":{"officer":true,"officer_title":"EVP and CMO"}}],"security":"Common Stock","published_at":"2019-03-01T22:16:33.000Z","date":"2019-02-28","kind":"exercise","acquired":true,"shares":2585,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of common stock."}],"balance_after":45337,"source":{"system":"sec-edgar","filing":"0001127602-19-009261","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1062822/000112760219009261/form4.xml","form_type":"4"}},{"id":3624051,"issuer":{"id":4970,"kind":"organization","name":"LEXICON PHARMACEUTICALS, INC."},"owners":[{"id":149674,"kind":"person","name":"Lapuerta Pablo","position":1,"cik":"0001516368","reported_name":"Lapuerta Pablo","relationship":{"officer":true,"officer_title":"EVP and CMO"}}],"security":"Common Stock","published_at":"2019-03-01T22:16:33.000Z","date":"2019-02-28","kind":"exercise","acquired":true,"shares":4227,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of common stock."}],"balance_after":42752,"source":{"system":"sec-edgar","filing":"0001127602-19-009261","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1062822/000112760219009261/form4.xml","form_type":"4"}},{"id":3624050,"issuer":{"id":4970,"kind":"organization","name":"LEXICON PHARMACEUTICALS, INC."},"owners":[{"id":149674,"kind":"person","name":"Lapuerta Pablo","position":1,"cik":"0001516368","reported_name":"Lapuerta Pablo","relationship":{"officer":true,"officer_title":"EVP and CMO"}}],"security":"Common Stock","published_at":"2019-03-01T22:16:33.000Z","date":"2019-02-28","kind":"exercise","acquired":true,"shares":4550,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of common stock."}],"balance_after":38525,"source":{"system":"sec-edgar","filing":"0001127602-19-009261","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1062822/000112760219009261/form4.xml","form_type":"4"}},{"id":3668833,"issuer":{"id":4970,"kind":"organization","name":"LEXICON PHARMACEUTICALS, INC."},"owners":[{"id":149674,"kind":"person","name":"Lapuerta Pablo","position":1,"cik":"0001516368","reported_name":"Lapuerta Pablo","relationship":{"officer":true,"officer_title":"EVP and CMO"}}],"security":"Restricted Stock Units","published_at":"2019-02-08T23:05:21.000Z","date":"2019-02-07","kind":"grant","acquired":true,"shares":70390,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit represents a contingent right to receive one share of common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Restricted stock units vest with respect to one third of the shares subject to the restricted stock units on February 28, 2020 and vest an additional one third on February 28 of each of the two succeeding years thereafter."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Restricted stock units vest with respect to one third of the shares subject to the restricted stock units on February 28, 2020 and vest an additional one third on February 28 of each of the two succeeding years thereafter."}],"balance_after":70390,"derivative":{"underlying":"Common Stock","underlying_shares":70390},"source":{"system":"sec-edgar","filing":"0001127602-19-004879","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1062822/000112760219004879/form4.xml","form_type":"4"}},{"id":3668832,"issuer":{"id":4970,"kind":"organization","name":"LEXICON PHARMACEUTICALS, INC."},"owners":[{"id":149674,"kind":"person","name":"Lapuerta Pablo","position":1,"cik":"0001516368","reported_name":"Lapuerta Pablo","relationship":{"officer":true,"officer_title":"EVP and CMO"}}],"security":"Stock Option (Right to Buy)","published_at":"2019-02-08T23:05:21.000Z","date":"2019-02-07","kind":"grant","acquired":true,"shares":130710,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Option vests with respect to 25% of the shares subject to the option on the first anniversary of grant (2/7/2020) and vests 1/48th per month for each month of service thereafter"}],"balance_after":130710,"derivative":{"exercise_price":5.16,"expiration_date":"2029-02-07","underlying":"Common Stock","underlying_shares":130710},"source":{"system":"sec-edgar","filing":"0001127602-19-004879","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1062822/000112760219004879/form4.xml","form_type":"4"}},{"id":4021136,"issuer":{"id":4970,"kind":"organization","name":"LEXICON PHARMACEUTICALS, INC."},"owners":[{"id":149674,"kind":"person","name":"Lapuerta Pablo","position":1,"cik":"0001516368","reported_name":"Lapuerta Pablo","relationship":{"officer":true,"officer_title":"EVP and CMO"}}],"security":"Restricted Stock Units","published_at":"2018-03-02T22:08:02.000Z","date":"2018-02-28","kind":"exercise","acquired":false,"shares":2585,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of common stock."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"Restricted stock units vest with respect to 25% of the shares subject to the restricted stock units on February 28, 2018 and vest an additional 25% on February 28 of each of the three succeeding years thereafter."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F6","text":"Restricted stock units vest with respect to 25% of the shares subject to the restricted stock units on February 28, 2018 and vest an additional 25% on February 28 of each of the three succeeding years thereafter."}],"balance_after":7755,"derivative":{"underlying":"Common Stock","underlying_shares":2585},"source":{"system":"sec-edgar","filing":"0001127602-18-009728","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1062822/000112760218009728/form4.xml","form_type":"4"}},{"id":4021135,"issuer":{"id":4970,"kind":"organization","name":"LEXICON PHARMACEUTICALS, INC."},"owners":[{"id":149674,"kind":"person","name":"Lapuerta Pablo","position":1,"cik":"0001516368","reported_name":"Lapuerta Pablo","relationship":{"officer":true,"officer_title":"EVP and CMO"}}],"security":"Restricted Stock Units","published_at":"2018-03-02T22:08:02.000Z","date":"2018-02-28","kind":"exercise","acquired":false,"shares":4228,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of common stock."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"Restricted stock units vest with respect to 25% of the shares subject to the restricted stock units on February 28, 2017 and vest an additional 25% on February 28 of each of the three succeeding years thereafter."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"Restricted stock units vest with respect to 25% of the shares subject to the restricted stock units on February 28, 2017 and vest an additional 25% on February 28 of each of the three succeeding years thereafter."}],"balance_after":8455,"derivative":{"underlying":"Common Stock","underlying_shares":4228},"source":{"system":"sec-edgar","filing":"0001127602-18-009728","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1062822/000112760218009728/form4.xml","form_type":"4"}},{"id":4021134,"issuer":{"id":4970,"kind":"organization","name":"LEXICON PHARMACEUTICALS, INC."},"owners":[{"id":149674,"kind":"person","name":"Lapuerta Pablo","position":1,"cik":"0001516368","reported_name":"Lapuerta Pablo","relationship":{"officer":true,"officer_title":"EVP and CMO"}}],"security":"Restricted Stock Units","published_at":"2018-03-02T22:08:02.000Z","date":"2018-02-28","kind":"exercise","acquired":false,"shares":4550,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of common stock."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Restricted stock units vest with respect to 25% of the shares subject to the restricted stock units on February 28, 2016 and vest an additional 25% on February 28 of each of the three succeeding years thereafter."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"Restricted stock units vest with respect to 25% of the shares subject to the restricted stock units on February 28, 2016 and vest an additional 25% on February 28 of each of the three succeeding years thereafter."}],"balance_after":4550,"derivative":{"underlying":"Common Stock","underlying_shares":4550},"source":{"system":"sec-edgar","filing":"0001127602-18-009728","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1062822/000112760218009728/form4.xml","form_type":"4"}},{"id":4021133,"issuer":{"id":4970,"kind":"organization","name":"LEXICON PHARMACEUTICALS, INC."},"owners":[{"id":149674,"kind":"person","name":"Lapuerta Pablo","position":1,"cik":"0001516368","reported_name":"Lapuerta Pablo","relationship":{"officer":true,"officer_title":"EVP and CMO"}}],"security":"Restricted Stock Units","published_at":"2018-03-02T22:08:02.000Z","date":"2018-02-28","kind":"exercise","acquired":false,"shares":2821,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of common stock."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Restricted stock units vest with respect to 25% of the shares subject to the restricted stock units on February 28, 2015 and vest an additional 25% on February 28 of each of the three succeeding years thereafter."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Restricted stock units vest with respect to 25% of the shares subject to the restricted stock units on February 28, 2015 and vest an additional 25% on February 28 of each of the three succeeding years thereafter."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":2821},"source":{"system":"sec-edgar","filing":"0001127602-18-009728","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1062822/000112760218009728/form4.xml","form_type":"4"}},{"id":4021132,"issuer":{"id":4970,"kind":"organization","name":"LEXICON PHARMACEUTICALS, INC."},"owners":[{"id":149674,"kind":"person","name":"Lapuerta Pablo","position":1,"cik":"0001516368","reported_name":"Lapuerta Pablo","relationship":{"officer":true,"officer_title":"EVP and CMO"}}],"security":"Common Stock","published_at":"2018-03-02T22:08:02.000Z","date":"2018-02-28","kind":"tax_withholding","acquired":false,"shares":4822,"price":8.53,"value":41131.66,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"Withholding of a portion of issued shares by the Company in satisfaction of shareholder's tax withholding obligations with respect thereto."}],"balance_after":33975,"source":{"system":"sec-edgar","filing":"0001127602-18-009728","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1062822/000112760218009728/form4.xml","form_type":"4"}},{"id":4021131,"issuer":{"id":4970,"kind":"organization","name":"LEXICON PHARMACEUTICALS, INC."},"owners":[{"id":149674,"kind":"person","name":"Lapuerta Pablo","position":1,"cik":"0001516368","reported_name":"Lapuerta Pablo","relationship":{"officer":true,"officer_title":"EVP and CMO"}}],"security":"Common Stock","published_at":"2018-03-02T22:08:02.000Z","date":"2018-02-28","kind":"exercise","acquired":true,"shares":2585,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of common stock."}],"balance_after":38797,"source":{"system":"sec-edgar","filing":"0001127602-18-009728","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1062822/000112760218009728/form4.xml","form_type":"4"}},{"id":4021130,"issuer":{"id":4970,"kind":"organization","name":"LEXICON PHARMACEUTICALS, INC."},"owners":[{"id":149674,"kind":"person","name":"Lapuerta Pablo","position":1,"cik":"0001516368","reported_name":"Lapuerta Pablo","relationship":{"officer":true,"officer_title":"EVP and CMO"}}],"security":"Common Stock","published_at":"2018-03-02T22:08:02.000Z","date":"2018-02-28","kind":"exercise","acquired":true,"shares":4228,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of common stock."}],"balance_after":36212,"source":{"system":"sec-edgar","filing":"0001127602-18-009728","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1062822/000112760218009728/form4.xml","form_type":"4"}},{"id":4021129,"issuer":{"id":4970,"kind":"organization","name":"LEXICON PHARMACEUTICALS, INC."},"owners":[{"id":149674,"kind":"person","name":"Lapuerta Pablo","position":1,"cik":"0001516368","reported_name":"Lapuerta Pablo","relationship":{"officer":true,"officer_title":"EVP and CMO"}}],"security":"Common Stock","published_at":"2018-03-02T22:08:02.000Z","date":"2018-02-28","kind":"exercise","acquired":true,"shares":4550,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of common stock."}],"balance_after":31984,"source":{"system":"sec-edgar","filing":"0001127602-18-009728","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1062822/000112760218009728/form4.xml","form_type":"4"}},{"id":4021128,"issuer":{"id":4970,"kind":"organization","name":"LEXICON PHARMACEUTICALS, INC."},"owners":[{"id":149674,"kind":"person","name":"Lapuerta Pablo","position":1,"cik":"0001516368","reported_name":"Lapuerta Pablo","relationship":{"officer":true,"officer_title":"EVP and CMO"}}],"security":"Common Stock","published_at":"2018-03-02T22:08:02.000Z","date":"2018-02-28","kind":"exercise","acquired":true,"shares":2821,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of common stock."}],"balance_after":27434,"source":{"system":"sec-edgar","filing":"0001127602-18-009728","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1062822/000112760218009728/form4.xml","form_type":"4"}},{"id":4066529,"issuer":{"id":4970,"kind":"organization","name":"LEXICON PHARMACEUTICALS, INC."},"owners":[{"id":149674,"kind":"person","name":"Lapuerta Pablo","position":1,"cik":"0001516368","reported_name":"Lapuerta Pablo","relationship":{"officer":true,"officer_title":"EVP and CMO"}}],"security":"Stock Option (Right to Buy)","published_at":"2018-02-12T22:12:30.000Z","date":"2018-02-08","kind":"grant","acquired":true,"shares":72330,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Option vests with respect to 25% of the shares subject to the option on the first anniversary of grant (2/8/2019) and vests 1/48th per month for each month of service thereafter."}],"balance_after":72330,"derivative":{"exercise_price":9.79,"expiration_date":"2028-02-08","underlying":"Common Stock","underlying_shares":72330},"source":{"system":"sec-edgar","filing":"0001127602-18-005201","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1062822/000112760218005201/form4.xml","form_type":"4"}},{"id":4066528,"issuer":{"id":4970,"kind":"organization","name":"LEXICON PHARMACEUTICALS, INC."},"owners":[{"id":149674,"kind":"person","name":"Lapuerta Pablo","position":1,"cik":"0001516368","reported_name":"Lapuerta Pablo","relationship":{"officer":true,"officer_title":"EVP and CMO"}}],"security":"Restricted Stock Units","published_at":"2018-02-12T22:12:30.000Z","date":"2018-02-08","kind":"grant","acquired":true,"shares":25710,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Restricted stock units vest with respect to one third of the shares subject to the restricted stock units on February 28, 2019 and vest an additional one third on February 28 of each of the two succeeding years thereafter."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Restricted stock units vest with respect to one third of the shares subject to the restricted stock units on February 28, 2019 and vest an additional one third on February 28 of each of the two succeeding years thereafter."}],"balance_after":25710,"derivative":{"underlying":"Common Stock","underlying_shares":25710},"source":{"system":"sec-edgar","filing":"0001127602-18-005201","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1062822/000112760218005201/form4.xml","form_type":"4"}},{"id":4414886,"issuer":{"id":4970,"kind":"organization","name":"LEXICON PHARMACEUTICALS, INC."},"owners":[{"id":149674,"kind":"person","name":"Lapuerta Pablo","position":1,"cik":"0001516368","reported_name":"Lapuerta Pablo","relationship":{"officer":true,"officer_title":"EVP and CMO"}}],"security":"Restricted Stock Units (Phantom Stock)","published_at":"2017-03-01T23:49:10.000Z","date":"2017-02-28","kind":"exercise","acquired":false,"shares":4227,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of common stock."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"Restricted stock units vest with respect to 25% of the shares subject to the restricted stock units on February 28, 2017 and vest an additional 25% on February 28 of each of the three succeeding years thereafter."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F6","text":"Restricted stock units vest with respect to 25% of the shares subject to the restricted stock units on February 28, 2017 and vest an additional 25% on February 28 of each of the three succeeding years thereafter."}],"balance_after":12683,"derivative":{"underlying":"Common Stock","underlying_shares":4227},"source":{"system":"sec-edgar","filing":"0001127602-17-009394","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1062822/000112760217009394/form4.xml","form_type":"4"}},{"id":4414885,"issuer":{"id":4970,"kind":"organization","name":"LEXICON PHARMACEUTICALS, INC."},"owners":[{"id":149674,"kind":"person","name":"Lapuerta Pablo","position":1,"cik":"0001516368","reported_name":"Lapuerta Pablo","relationship":{"officer":true,"officer_title":"EVP and CMO"}}],"security":"Restricted Stock Units (Phantom Stock)","published_at":"2017-03-01T23:49:10.000Z","date":"2017-02-28","kind":"exercise","acquired":false,"shares":4550,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of common stock."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"Restricted stock units vest with respect to 25% of the shares subject to the restricted stock units on February 28, 2016 and vest an additional 25% on February 28 of each of the three succeeding years thereafter."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"Restricted stock units vest with respect to 25% of the shares subject to the restricted stock units on February 28, 2016 and vest an additional 25% on February 28 of each of the three succeeding years thereafter."}],"balance_after":9100,"derivative":{"underlying":"Common Stock","underlying_shares":4550},"source":{"system":"sec-edgar","filing":"0001127602-17-009394","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1062822/000112760217009394/form4.xml","form_type":"4"}},{"id":4414884,"issuer":{"id":4970,"kind":"organization","name":"LEXICON PHARMACEUTICALS, INC."},"owners":[{"id":149674,"kind":"person","name":"Lapuerta Pablo","position":1,"cik":"0001516368","reported_name":"Lapuerta Pablo","relationship":{"officer":true,"officer_title":"EVP and CMO"}}],"security":"Restricted Stock Units (Phantom Stock)","published_at":"2017-03-01T23:49:10.000Z","date":"2017-02-28","kind":"exercise","acquired":false,"shares":2822,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of common stock."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Restricted stock units vest with respect to 25% of the shares subject to the restricted stock units on February 28, 2015 and vest an additional 25% on February 28 of each of the three succeeding years thereafter."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"Restricted stock units vest with respect to 25% of the shares subject to the restricted stock units on February 28, 2015 and vest an additional 25% on February 28 of each of the three succeeding years thereafter."}],"balance_after":2821,"derivative":{"underlying":"Common Stock","underlying_shares":2822},"source":{"system":"sec-edgar","filing":"0001127602-17-009394","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1062822/000112760217009394/form4.xml","form_type":"4"}},{"id":4414883,"issuer":{"id":4970,"kind":"organization","name":"LEXICON PHARMACEUTICALS, INC."},"owners":[{"id":149674,"kind":"person","name":"Lapuerta Pablo","position":1,"cik":"0001516368","reported_name":"Lapuerta Pablo","relationship":{"officer":true,"officer_title":"EVP and CMO"}}],"security":"Restricted Stock Units (Phantom Stock)","published_at":"2017-03-01T23:49:10.000Z","date":"2017-02-28","kind":"exercise","acquired":false,"shares":2500,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of common stock."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Restricted stock units vest with respect to 25% of the shares subject to the restricted stock units on February 28, 2014 and vest an additional 25% on February 28 of each of the three succeeding years thereafter."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Restricted stock units vest with respect to 25% of the shares subject to the restricted stock units on February 28, 2014 and vest an additional 25% on February 28 of each of the three succeeding years thereafter."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":2500},"source":{"system":"sec-edgar","filing":"0001127602-17-009394","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1062822/000112760217009394/form4.xml","form_type":"4"}},{"id":4414882,"issuer":{"id":4970,"kind":"organization","name":"LEXICON PHARMACEUTICALS, INC."},"owners":[{"id":149674,"kind":"person","name":"Lapuerta Pablo","position":1,"cik":"0001516368","reported_name":"Lapuerta Pablo","relationship":{"officer":true,"officer_title":"EVP and CMO"}}],"security":"Common Stock","published_at":"2017-03-01T23:49:10.000Z","date":"2017-02-28","kind":"tax_withholding","acquired":false,"shares":5252,"price":16.45,"value":86395.4,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"Withholding of a portion of issued shares by the Company in satisfaction of shareholder's tax withholding obligations with respect thereto."}],"balance_after":24613,"source":{"system":"sec-edgar","filing":"0001127602-17-009394","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1062822/000112760217009394/form4.xml","form_type":"4"}},{"id":4414881,"issuer":{"id":4970,"kind":"organization","name":"LEXICON PHARMACEUTICALS, INC."},"owners":[{"id":149674,"kind":"person","name":"Lapuerta Pablo","position":1,"cik":"0001516368","reported_name":"Lapuerta Pablo","relationship":{"officer":true,"officer_title":"EVP and CMO"}}],"security":"Common Stock","published_at":"2017-03-01T23:49:10.000Z","date":"2017-02-28","kind":"exercise","acquired":true,"shares":4227,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of common stock."}],"balance_after":29865,"source":{"system":"sec-edgar","filing":"0001127602-17-009394","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1062822/000112760217009394/form4.xml","form_type":"4"}},{"id":4414880,"issuer":{"id":4970,"kind":"organization","name":"LEXICON PHARMACEUTICALS, INC."},"owners":[{"id":149674,"kind":"person","name":"Lapuerta Pablo","position":1,"cik":"0001516368","reported_name":"Lapuerta Pablo","relationship":{"officer":true,"officer_title":"EVP and CMO"}}],"security":"Common Stock","published_at":"2017-03-01T23:49:10.000Z","date":"2017-02-28","kind":"exercise","acquired":true,"shares":4550,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of common stock."}],"balance_after":25638,"source":{"system":"sec-edgar","filing":"0001127602-17-009394","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1062822/000112760217009394/form4.xml","form_type":"4"}},{"id":4414879,"issuer":{"id":4970,"kind":"organization","name":"LEXICON PHARMACEUTICALS, INC."},"owners":[{"id":149674,"kind":"person","name":"Lapuerta Pablo","position":1,"cik":"0001516368","reported_name":"Lapuerta Pablo","relationship":{"officer":true,"officer_title":"EVP and CMO"}}],"security":"Common Stock","published_at":"2017-03-01T23:49:10.000Z","date":"2017-02-28","kind":"exercise","acquired":true,"shares":2822,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of common stock."}],"balance_after":21088,"source":{"system":"sec-edgar","filing":"0001127602-17-009394","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1062822/000112760217009394/form4.xml","form_type":"4"}},{"id":4414878,"issuer":{"id":4970,"kind":"organization","name":"LEXICON PHARMACEUTICALS, INC."},"owners":[{"id":149674,"kind":"person","name":"Lapuerta Pablo","position":1,"cik":"0001516368","reported_name":"Lapuerta Pablo","relationship":{"officer":true,"officer_title":"EVP and CMO"}}],"security":"Common Stock","published_at":"2017-03-01T23:49:10.000Z","date":"2017-02-28","kind":"exercise","acquired":true,"shares":2500,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of common stock."}],"balance_after":18266,"source":{"system":"sec-edgar","filing":"0001127602-17-009394","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1062822/000112760217009394/form4.xml","form_type":"4"}},{"id":4454516,"issuer":{"id":4970,"kind":"organization","name":"LEXICON PHARMACEUTICALS, INC."},"owners":[{"id":149674,"kind":"person","name":"Lapuerta Pablo","position":1,"cik":"0001516368","reported_name":"Lapuerta Pablo","relationship":{"officer":true,"officer_title":"EVP and CMO"}}],"security":"Restricted Stock Units (Phantom Stock)","published_at":"2017-02-13T21:25:45.000Z","date":"2017-02-09","kind":"grant","acquired":true,"shares":10340,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit represents a contingent right to receive one share of common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Restricted stock units vest with respect to 25% of the shares subject to the restricted stock units on February 28, 2018 and vest an additional 25% on February 28 of each of the three succeeding years thereafter."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Restricted stock units vest with respect to 25% of the shares subject to the restricted stock units on February 28, 2018 and vest an additional 25% on February 28 of each of the three succeeding years thereafter."}],"balance_after":10340,"derivative":{"underlying":"Common Stock","underlying_shares":10340},"source":{"system":"sec-edgar","filing":"0001127602-17-005421","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1062822/000112760217005421/form4.xml","form_type":"4"}},{"id":4454515,"issuer":{"id":4970,"kind":"organization","name":"LEXICON PHARMACEUTICALS, INC."},"owners":[{"id":149674,"kind":"person","name":"Lapuerta Pablo","position":1,"cik":"0001516368","reported_name":"Lapuerta Pablo","relationship":{"officer":true,"officer_title":"EVP and CMO"}}],"security":"Stock Option (Right to Buy)","published_at":"2017-02-13T21:25:45.000Z","date":"2017-02-09","kind":"grant","acquired":true,"shares":41370,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Option vests with respect to 25% of the shares subject to the option on the first anniversary of grant (2/9/2018) and vests 1/48th per month for each month of service thereafter"}],"balance_after":41370,"derivative":{"exercise_price":14.44,"expiration_date":"2027-02-09","underlying":"Common Stock","underlying_shares":41370},"source":{"system":"sec-edgar","filing":"0001127602-17-005421","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1062822/000112760217005421/form4.xml","form_type":"4"}}]}